|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000158321 |
Summary for AUTS2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000158321 | Gene symbol | AUTS2 |
| Gene name | activator of transcription and developmental regulator AUTS2 | |
| HGNC | 14262 | |
| Entrez ID | 26053 | |
| Gene type | protein_coding | |
| Synonyms | AUTS2|KIAA0442|FBRSL2 | |
| UniProtAcc | Q8WXX7 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for AUTS2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| AUTS2 | 1.14e+03 | -1.85e+00 | 4.10e-01 | -4.52e+00 | 6.08e-06 | 3.61e-05 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| AUTS2 | 1.26e+03 | -1.05e+00 | 3.25e-01 | -3.23e+00 | 1.26e-03 | 6.19e-03 | KIRP |
Top |
Sex-biased somatic mutation for AUTS2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for AUTS2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg21393713 | chr7:69599815 | CGI:chr7:69597388-69600051 | promoter,exon,CDS,gene body | 1.41e-01 | 1.87e-02 | 3.29e+00 | 9.88e-04 | 1.92e-03 | 1.22e-01 |
| LUAD | cg08676249 | chr7:69599882 | CGI:chr7:69597388-69600051 | promoter,exon,CDS,gene body | 2.09e-01 | 1.02e-01 | 3.74e+00 | 1.83e-04 | 4.66e-04 | 1.07e-01 |
| HNSC | cg08676249 | chr7:69599882 | CGI:chr7:69597388-69600051 | promoter,exon,CDS,gene body | 2.07e-01 | 1.06e-01 | 3.52e+00 | 4.37e-04 | 8.99e-04 | 1.00e-01 |
| COAD | cg21591173 | chr7:69598489 | CGI:chr7:69597388-69600051 | promoter | 1.83e-01 | 2.17e-02 | 2.15e+00 | 3.13e-02 | 3.49e-02 | 1.61e-01 |
| BLCA | cg08676249 | chr7:69599882 | CGI:chr7:69597388-69600051 | promoter,exon,CDS,gene body | 2.44e-01 | 1.15e-01 | 2.24e+00 | 2.53e-02 | 2.94e-02 | 1.29e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg20547575 | chr7:69600365 | CGI:chr7:69597388-69600051 | promoter,gene body | 2.36e-01 | 3.54e-01 | -2.27e+00 | 2.32e-02 | 2.71e-02 | -1.18e-01 |
Top |
Exon skipping events with PSI in TCGA for AUTS2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| READ | exon_skip_466700 | 8.51e-01 | 7.12e-01 | 2.97e+00 | 2.95e-03 | 1.20e-02 | 1.39e-01 |
| KICH | exon_skip_466700 | 6.71e-01 | 7.93e-01 | -2.66e+00 | 7.80e-03 | 1.78e-02 | -1.22e-01 |
Top |
RNA A-to-I editing events in TCGA for AUTS2 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | AUTS2-002 | chr7_70157378_+ | 1.88e-01 | 3.23e-01 | -2.56e+00 | 1.04e-02 | 4.96e-02 | -1.35e-01 |
| STAD | AUTS2-002 | chr7_70157391_+ | 3.74e-01 | 5.20e-01 | -2.08e+00 | 3.74e-02 | 4.96e-02 | -1.46e-01 |
| LAML | AUTS2-002 | chr7_70440126_+ | 3.15e-01 | 5.67e-01 | -2.61e+00 | 9.02e-03 | 4.94e-02 | -2.53e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for AUTS2 |
TFs related to AUTS2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | LEF1 | AUTS2 | 4.12e+00 | 9.81e-01 | 3.13e+00 | 5.76e-03 | Male-biased |
AUTS2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for AUTS2 |
RBPs related to ES in AUTS2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| COAD | KHDRBS3 | exon_skip_466708 | 7.70e+00 | 5.80e-03 | 8.08e+00 | 9.86e-01 | Female-biased |
| COAD | QKI | exon_skip_466708 | 1.18e+01 | 2.13e-03 | 1.23e+01 | 9.97e-01 | Female-biased |
| BRCA | CNOT4 | exon_skip_466704 | 1.07e+01 | 9.82e-01 | 1.02e+01 | 1.68e-02 | Male-biased |
| THCA | KHDRBS3 | exon_skip_466708 | 8.22e+00 | 9.87e-01 | 7.88e+00 | 5.21e-03 | Male-biased |
| THCA | QKI | exon_skip_466708 | 1.23e+01 | 9.98e-01 | 1.18e+01 | 1.06e-03 | Male-biased |
| PCPG | QKI | exon_skip_466708 | 1.28e+01 | 9.98e-01 | 1.24e+01 | 2.02e-03 | Male-biased |
| LGG | SAMD4A | exon_skip_466705 | 8.48e+00 | 4.08e-03 | 8.89e+00 | 9.91e-01 | Female-biased |
AUTS2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs17351971 | chr7:78437954:A:G | - | 0.147034921875491 | 0.00700364716456317 | STAD | Female-baised eQTL |
| rs12538875 | chr7:63032753:C:T | - | 0.10136229152625 | 0.0470564915472802 | BLCA | Female-baised eQTL |
| rs2159708 | chr7:79219639:T:A | - | -0.0805525761630561 | 0.0116827149441669 | LUAD | Female-baised eQTL |
| rs4730118 | chr7:78205467:T:A | - | 0.12920401711238 | 0.0451872854073128 | LUAD | Female-baised eQTL |
| rs848811 | chr7:79242727:G:C | - | -0.0792989961287393 | 0.0473775065733219 | LUAD | Female-baised eQTL |
| rs10253536 | chr7:79264759:T:C | - | 0.0750971720327785 | 0.0478364290547477 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2903935 | chr7:78023924:C:T | - | -0.0625994016845131 | 0.0220113428825436 | LGG | Male-baised eQTL |
| rs1981589 | chr7:78022947:T:C | - | -0.0619744529759835 | 0.0254338585030017 | LGG | Male-baised eQTL |
| rs2471591 | chr7:78020811:T:G | - | -0.0587854251263853 | 0.0456507673044505 | LGG | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20680265 | chr7:70729616 | gene | -0.235835298995461 | 8.85608830797618e-05 | -0.32395910807832284 | 2.7133288709775097e-06 | KIRP |
| cg04601228 | chr7:70631043 | gene | -0.167916479423498 | 2.3544255984439e-06 | -0.3150306942048915 | 1.8766499584487638e-08 | BLCA |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg19268017 | chr7:70595849 | gene | -0.124708923976546 | 7.14795923720259e-07 | -0.35869677747532147 | 1.1478228668909975e-08 | LGG |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs73168758 | chr7:69914825:G:A | Distant upstream | -0.0773145410059532 | 0.0330615685049442 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10229336 | chr7:69888667:T:C | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs73168747 | chr7:69896390:C:T | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs9690769 | chr7:69901074:C:T | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs7777243 | chr7:69907566:G:A | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs7781664 | chr7:69908201:G:A | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs28393394 | chr7:69916465:C:T | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs6968426 | chr7:69916863:C:G | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs11762487 | chr7:69927316:G:A | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10216186 | chr7:69930182:C:A | Distant upstream | -0.0756041557138129 | 0.0358408439392822 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs17141032 | chr7:69938904:T:C | Distant upstream | -0.0756468261892626 | 0.0361371035463574 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs9690738 | chr7:69941157:C:A | Distant upstream | -0.0756468261892626 | 0.0361371035463574 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10272781 | chr7:69821901:G:C | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10275721 | chr7:69825410:T:G | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs7784950 | chr7:69826172:G:A | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10487943 | chr7:69826447:A:C | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10239569 | chr7:69828525:G:T | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs11771899 | chr7:69829435:C:A | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs17140938 | chr7:69831661:C:T | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10216097 | chr7:69834676:C:A | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs73154605 | chr7:69847101:C:T | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs28812289 | chr7:69850330:C:T | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs7780835 | chr7:69855204:C:T | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10279669 | chr7:69856384:T:C | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs28667218 | chr7:69870448:A:T | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs73168740 | chr7:69878763:C:T | Distant upstream | -0.079273391604914 | 0.0364125057349302 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10278978 | chr7:69801744:A:G | Distant upstream | -0.0788367147105752 | 0.0390691238162536 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs11771751 | chr7:69785320:A:G | Distant upstream | -0.0787026739515044 | 0.0395394540688868 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs11769033 | chr7:69785919:C:G | Distant upstream | -0.0787026739515044 | 0.0395394540688868 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs73172903 | chr7:69806819:T:A | Distant upstream | -0.0787026739515044 | 0.0395394540688868 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10245690 | chr7:69808256:A:G | Distant upstream | -0.0787026739515044 | 0.0395394540688868 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10274419 | chr7:69817159:G:C | Distant upstream | -0.0787026739515044 | 0.0395394540688868 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs61370051 | chr7:69879431:C:T | Distant upstream | -0.0785860996144049 | 0.040376649646696 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs28464032 | chr7:70194106:T:C | Distant upstream | -0.0732649565397763 | 0.0441757213904012 | LGG | Female-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs142174069 | chr7:70219592:G:T | Distant upstream | -0.0709172975977593 | 0.0468327951454074 | LGG | Female-baised sQTL |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs56115165 | chr7:70754939:C:T | Distant upstream | -0.050380854037532 | 0.00589586903199557 | KIRC | Male-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs7796230 | chr7:71635842:A:C | Distant downstream | 0.0376641683684476 | 0.0068719380804994 | COAD | Male-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10243782 | chr7:71645915:G:T | Distant downstream | -0.0359805708425277 | 0.0203543416615284 | COAD | Male-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs11765732 | chr7:71659209:C:T | Distant downstream | 0.034552593217403 | 0.0250872825949339 | COAD | Male-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs10262605 | chr7:71659122:A:C | Distant downstream | -0.0345253786935617 | 0.0323594212429806 | COAD | Male-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs605586 | chr7:71660263:C:T | Distant downstream | 0.0328667037596519 | 0.0331720966025962 | COAD | Male-baised sQTL |
| exon_skip_466700 | chr7:70774027:70774099 | In-frame | rs605637 | chr7:71660310:G:A | Distant downstream | 0.0317857563184354 | 0.0461149813937626 | COAD | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of AUTS2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000158321 | AUTS2 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
| ENSG00000158321 | AUTS2 | C0014544 | Epilepsy | 1 | CTD_human |
| ENSG00000158321 | AUTS2 | C0036341 | Schizophrenia | 2 | PSYGENET |
| ENSG00000158321 | AUTS2 | C0086237 | Epilepsy, Cryptogenic | 1 | CTD_human |
| ENSG00000158321 | AUTS2 | C0236018 | Aura | 1 | CTD_human |
| ENSG00000158321 | AUTS2 | C0751111 | Awakening Epilepsy | 1 | CTD_human |
| ENSG00000158321 | AUTS2 | C4014435 | MENTAL RETARDATION, AUTOSOMAL DOMINANT 26 | 1 | CTD_human |